Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04845217 · ClinicalTrials.gov registry record · Phase 1
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
A Phase 1 study of Interstitial Cystitis, sponsored by University of Louisville.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04845217: Recruiting Phase 1 study of Interstitial Cystitis, sponsored by University of Louisville.
NCT04845217 is a Phase 1 study of Interstitial Cystitis that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 100 participants, below the 358-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04845217, a Phase 1 study of Interstitial Cystitis, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the use of peppermint oil as a treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
Primary Outcome
Participant responses to the O'Leary/Sant questionnaire assessing IC/BPS symptoms will be compared at baseline and after starting treatment with peppermint oil.
Conditions Studied
Interventions
- DRUG Peppermint oil
- DRUG Coconut Oil
Study Locations (1)
Kentucky
- Springs Medical Center - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2023-12 |
| Phase | Phase 1 |
What NCT04845217 shows while recruiting
NCT04845217 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 358-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Interstitial Cystitis appearing as the primary indexed condition, and to 2 interventions - of which Peppermint oil is the first listed.
NCT04845217 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT04845217 about?
NCT04845217 is a clinical study titled "Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome". The purpose of this study is to assess the use of peppermint oil as a treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
What is the current status of trial NCT04845217?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2021-09-15. Estimated completion is 2023-12.
What conditions does trial NCT04845217 study?
This clinical trial studies the following conditions: Interstitial Cystitis.
What interventions are being tested in trial NCT04845217?
The interventions under investigation include: Peppermint oil (DRUG), Coconut Oil (DRUG).
Who is sponsoring clinical trial NCT04845217?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04845217 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04845217's enrollment target sits among peer trials
100 11th of 26 higher than 15 of 26 other Interstitial Cystitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Cystitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
Identifying Genetic Causes of IC/BPS
RECRUITING
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
RECRUITING · Phase 2
-
Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI